MyMD Pharmaceuticals (MYMD) Financials

$1.60

$0.27 (20.30%)

As on 25-Sep-2024 09:30EDT

Market cap

$4 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.4

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Operating Revenue	--	--	--	--	--	1.58
Cost of Revenue	--	--	--	--	0.03	0.07
Gross Profit	--	--	--	--	-0.03	1.50
Operating Expenses	13.40	17.12	15.28	28.20	8.30	3.32
Operating Profit (EBIT)	-13.40	-17.12	-15.28	-28.81	-9.49	-3.40
Other Income	--	--	--	--	0.13	--
Profit before Tax	-17.69	-4.00	-15.20	-29.89	-9.49	-3.38
Provision for Tax	2.36	4.22	-0.09	-0.01	1.19	-0.08
Profit after Tax (Net Income)	-17.69	-4.00	-15.11	-29.88	-10.68	-3.89
Minority Interest	--	--	--	--	--	--
Consolidated Profit	2.88	--	--	-29.89	-8.93	-9.64

Liabilities ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Shareholder's Funds	0.38	12.77	14.70	23.65	-5.26	9.36
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	20.22	0.10	0.08	0.13	3.59	0.99
Current Liabilities	5.78	4.99	2.77	1.04	2.35	1.53
Total Liabilities	5.78	17.86	17.54	24.81	0.68	10.88

Assets ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Non-Current Assets	12.02	12.05	12.14	12.15	0.53	0.57
Current Assets	14.36	5.82	5.40	12.67	0.15	10.31
Total Assets	32.16	17.86	17.54	24.81	0.68	10.88
Total Debt*	--	0.05	0.14	0.15	4.13	1.00
Net Current Assets	8.57	0.83	2.63	11.63	-2.20	--

Cashflow ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Cash From Operating Activities	--	-12.98	-12.27	-19.52	-4.66	-3.07
Cash Flow from Investing Activities	--	--	--	19.85	-8.76	-3.94
Cash from Financing Activities	--	13.07	5.55	0.07	4.68	6.97
Net Cash Inflow / Outflow	--	--	--	--	17.99	--

Financials Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
ROCE (%)	--	-28.92	-78.23	-263.59	-231.29	-48.02
ROE (%)	-268.87	-29.12	-78.83	-324.96	-521.20	-51.20
ROA (%)	-59.11	-22.60	-71.36	-234.45	-184.74	-41.60
EBIT Margin (%)	--	--	--	--	--	-215.41
Net Margin (%)	--	--	--	--	-8,000.42	-246.55
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Revenue Growth (%)	--	--	--	--	-1.00	-0.05
EBIT Growth (%)	58.02	-119.09	46.95	-203.64	-179.30	68.69
Net Profit Growth (%)	-48.05	73.53	49.42	-179.78	-174.67	64.16
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Price / Earnings	--	--	--	--	--	--
Price / Book Value	0.44	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.03	0.28	0.31	0.40	1.54	2.61
Close Price ($)	1.84	7.77	34.50	181.80	119.40	192.00
High Price ($)	63.90	89.39	190.50	314.40	531.00	2,217.60
Low Price ($)	1.75	6.06	27.00	99.00	93.00	159.94
Market Cap ($ Cr)	4.31	--	--	--	--	--

Solvency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debt to Equity	--	0.00	0.01	0.01	-0.79	0.11
Short term debt to equity ratio	--	0.00	0.00	0.00	-0.10	0.00
Current Ratio	2.48	1.17	1.95	12.18	0.06	6.74
Quick Ratio	2.48	--	--	--	0.70	6.61
Interest Coverage	-15.40	--	-178.90	-47.35	-7.96	--

Operating Efficiency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debtors to sales (%)	--	--	--	--	--	2.72
Asset Turnover	--	--	--	--	--	0.17
Receivable days	--	--	--	--	--	25.38
Inventory Days	--	--	--	--	-8,099.14	1,933.79
Payable days	--	--	--	--	14,888.25	3,170.70
Cash Conversion Cycle	--	--	--	--	--	-1,211.53

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.